High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung

Human Gene Therapy

Volumn 18, Issue 4, 2007, Pages 344-354

  Halbert, Christine L ^a   Lam, Siu Ling ^a   Miller, A Dusty ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BETA GLOBIN; CAPSID PROTEIN; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS TYPE 6; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; EMBRYO; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LUNG; MOUSE; NONHUMAN; NOSE MUCOSA; PROMOTER REGION; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; ROUS SARCOMA ONCOVIRUS; TRACHEA MUCOSA; VIRAL GENE DELIVERY SYSTEM;

ALKALINE PHOSPHATASE; ALTERNATIVE SPLICING; ANIMALS; CYTOMEGALOVIRUS; DEPENDOVIRUS; GENETIC VECTORS; GLOBINS; HUMANS; LUNG; MICE; PROMOTER REGIONS (GENETICS); TISSUE DISTRIBUTION; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 6; HUMAN HERPESVIRUS 5; MIRIDAE; RICE STRIPE VIRUS; ROUS SARCOMA VIRUS;

EID: 34248194614     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.182     Document Type: Article

References (39)

1. ALLEN, J.M., HALBERT, C.L., and MILLER, A.D. (2000). Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6. Mol. Ther. 1, 88-95.
2. BLANKINSHIP, M.J., GREGOREVIC, P., ALLEN, J.M., HARPER, S.Q., HARPER, H., HALBERT, C.L., MILLER, A.D., and CHAMBERLAIN, J.S. (2004). Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol. Ther. 10, 671-678.
3. BOISSY, R., and ASTELL, C.R. (1985). An Escherichia coli recBCs-bcBrecF host permits the deletion-resistant propagation of plasmid clones containing the 5′-terminal palindrome of minute virus of mice. Gene 35, 179-185.
4. BOSHART, M., WEBER, F., JAHN, G., DORSCH-HASLER, K., FLECKENSTEIN, B., and SCHAFFNER, W. (1985). A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41, 521-530.
5. DUAN, D., YUE, Y., and ENGELHARDT, J.F. (2001). Expanding AAV packaging capacity with trans-splicing or overlapping vectors: A quantitative comparison. Mol. Ther. 4, 383-391.
6. ENGELHARDT, J.F., YANKASKAS, J.R., ERNST, S.A., YANG, Y., MARINO, C.R., BOUCHER, R.C., COHN, J.A., and WILSON, J.M. (1992). Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat. Genet. 2, 240-248.
7. FISHER, K.J., JOOSS, K., ALSTON, J., YANG, Y., HAECKER, S.E., HIGH, K., PATHAK, R., RAPER, S.E., and WILSON, J.M. (1997). Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3, 306-312.
8. FOECKING, M.K., and HOFSTETTER, H. (1986). Powerful and versatile enhancer-promoter unit for mammalian expression vectors. Gene 45, 101-105.
9. FURTH, P.A., HENNIGHAUSEN, L., BAKER, C., BEATTY, B., and WOYCHICK, R. (1991). The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res. 19, 6205-6208.
10. GAO, G.P., ALVIRA, M.R., WANG, L., CALCEDO, R., JOHNSTON, J., and WILSON, J.M. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99, 11854-11859.
11. GREGOREVIC, P., BLANKINSHIP, M.J., ALLEN, J.M., CRAWFORD, R.W., MEUSE, L., MILLER, D.G., RUSSELL, D.W., and CHAMBERLAIN, J.S. (2004). Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat. Med. 10, 828-834.
12. GRUBB, B.R., PICKLES, R.J., YE, H., YANKASKAS, J.R., VICK, R.N., ENGELHARDT, J.F., WILSON, J.M., JOHNSON, L.G., and BOUCHER, R.C. (1994). Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371, 802-806.
13. HALBERT, C.L., and MILLER, A.D. (2004). AAV-mediated gene transfer to mouse lungs. Methods Mol. Biol. 246, 201-212.
14. HALBERT, C.L., STANDAERT, T.A., AITKEN, M.L., ALEXANDER, I.E., RUSSELL, D.W., and MILLER, A.D. (1997). Transduction by adeno-associated virus vectors in the rabbit airway: Efficiency, persistence, and readministration. J. Virol. 71, 5932-5941.
15. HALBERT, C.L., STANDAERT, T.A., WILSON, C.B., and MILLER, A.D. (1998). Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J. Virol. 72, 9795-9805.
16. HALBERT, C.L., RUTLEDGE, E.A., ALLEN, J.M., RUSSELL, D.W., and MILLER, A.D. (2000). Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol. 74, 1524-1532.
17. HALBERT, C.L., ALLEN, J.M., and MILLER, A.D. (2001). Adenoassociated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared with that of AAV2 vectors. J. Virol. 75, 6615-6624.
18. HALBERT, C.L., ALLEN, J.M., and MILLER, A.D. (2002). Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat. Biotechnol. 20, 697-701.
19. HALBERT, C.L., MILLER, A.D., McNAMARA, S., EMERSON, J., GIBSON, R.L., RAMSEY, B., and AITKEN, M.L. (2006). Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors. Hum. Gene Ther. 17, 440-447.
20. HERZOG, R.W., HAGSTROM, J.N., KUNG, S.H., TAI, S.J., WILSON, J.M., FISHER, K.J., and HIGH, K.A. (1997). Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A. 94, 5804-5809.
21. HERZOG, R.W., YANG, E.Y., COUTO, L.B., HAGSTROM, J.N., ELWELL, D., FIELDS, P.A., BURTON, M., BELLINGER, D.A., READ, M.S., BRINKHOUS, K.M., PODSAKOFF, G.M., NICHOLS, T.C., KURTZMAN, G.J., and HIGH, K.A. (1999). Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat. Med. 5, 56-63.
22. ISOMURA, H., TSURUMI, T., and STINSKI, M.F. (2004). Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication. J. Virol. 78, 12788-12799.
23. KAUFFMAN, S.L. (1980). Cell proliferation in the mammalian lung. Int. Rev. Exp. Pathol. 22, 131-191.
24. KAWAMOTO, S., SHI, Q., NITTA, Y., MIYAZAKI, J., and ALLEN, M.D. (2005). Widespread and early myocardial gene expression by adeno-associated virus vector type 6 with a β-actin hybrid promoter. Mol. Ther. 11, 980-985.
25. KESSLER, P.D., PODSAKOFF, G.M., CHEN, X., McQUISTON, S.A., COLOSI, P.C., MATELIS, L.A., KURTZMAN, G.J., and BYRNE, B.J. (1996). Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. U.S.A. 93, 14082-14087.
26. LASHMIT, P.E., LUNDQUIST, C.A., MEIER, J.L., and STINSKI, M.F. (2004). Cellular repressor inhibits human cytomegalovirus transcription from the UL127 promoter. J. Virol. 78, 5113-5123.
27. LUNDQUIST, C.A., MEIER, J.L., and STINSKI, M.F. (1999). A strong negative transcriptional regulatory region between the human cytomegalovirus UL127 gene and the major immediate-early enhancer. J. Virol. 73, 9039-9052.
28. NIWA, H., YAMAMURA, K., and MIYAZAKI, J. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-199.
29. SAWICKI, J.A., MORRIS, R.J., MONKS, B., SAKAI, K., and MIYAZAKI, J. (1998). A composite CMV-IE enhancer/β-actin promoter is ubiquitously expressed in mouse cutaneous epithelium. Exp. Cell Res. 244, 367-369.
30. SCHMIDT, E.V., CHRISTOPH, G., ZELLER, R., and LEDER, P. (1990). The cytomegalovirus enhancer: A pan-active control element in transgenic mice. Mol. Cell. Biol. 10, 4406-4411.
31. SEILER, M.P., MILLER, A.D., ZABNER, J., and HALBERT, C.L. (2006). Adeno-associated virus types 5 and 6 use distinct receptors for cell entry. Hum. Gene Ther. 17, 10-19.
32. THOMAS, C.E., STORM, T.A., HUANG, Z., and KAY, M.A. (2004). Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors. J. Virol. 78, 3110-3122.
33. VIRELLA-LOWELL, I., ZUSMAN, B., FOUST, K., LOILER, S., CONLON, T., SONG, S., CHESNUT, K.A., FERKOL, T., and FLOTTE, T.R. (2005). Enhancing rAAV vector expression in the lung. J. Gene Med. 7, 842-850.
34. WALTERS, R.W., YI, S.M., KESHAVJEE, S., BROWN, K.E., WELSH, M.J., CHIORINI, J.A., and ZABNER, J. (2001). Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276, 20610-20616.
35. WOLGAMOT, G., and MILLER, A.D. (1999). Replication of Mus dunni endogenous retrovirus depends on promoter activation followed by enhancer multimerization. J. Virol. 73, 9803-9809.
36. WU, Z., MILLER, E., AGBANDJE-McKENNA, M., and SAMULSKI, R.J. (2006). α2,3 and α2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J. Virol. 80, 9093-9103.
37. XIAO, W., CHIRMULE, N., BERTA, S.C., McCULLOUGH, B., GAO, G., and WILSON, J.M. (1999). Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 73, 3994-4003.
38. XIAO, X., LI, J., and SAMULSKI, R.J. (1996). Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098-8108.
39. YANKASKAS, R.J., SUCHINDRAN, H., SARKODI, B., NETTESHEIM, P., and RANDELL, S. (1993). Cystic fibrosis transmembrane conductance regulator (CFTR) protein is selectively expressed in ciliated airway epithelial cells [abstract]. Am. Rev. Respir. Dis. 147, A26.